Insecticidal Shampoo may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Insecticidal Shampoo in the following countries:
International Drug Name Search
Treating certain types of skin growths (actinic keratoses) or skin cancer (superficial basal cell carcinoma). It may also be used to treat external genital and perianal warts. It may also be used for other conditions as determined by your doctor.
Aldara is an immune response modifier. Exactly how it works is not known.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Aldara. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Aldara. Because little, if any, of Aldara is absorbed into the blood, the risk of it interacting with another medicine is low.
This may not be a complete list of interactions that may occur. Ask your health care provider if Aldara may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Aldara as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Aldara.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Back pain; changes in skin color; diarrhea; headache; itching, burning, mild pain, or tenderness at the application site; redness, dryness, flaking, swelling, or scabbing at the application site; small sores or mild drainage at the application site; thick or hardened skin at the application site; tiredness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue, unusual hoarseness); chest pain; fever, chills, or sore throat; irregular heartbeat; muscle pain or weakness; nausea; oozing, blistering, or bleeding at the application site; severe irritation or pain at the application site; sores or ulcers at the application site; swollen lymph glands; trouble urinating; vaginal pain or swelling.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Aldara side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness or fainting.
Store Aldara at room temperature, below 77 degrees F (25 degrees C). Do not freeze. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Aldara out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Aldara. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Class: Potassium-removing Agents
VA Class: AD400
CAS Number: 9003-59-2
Brands: Kayexalate, Kionex, SPS
A sulfonated cation-exchange resin used for the removal of excess potassium.a b c
Treatment of hyperkalemia.a b c Used as an adjunct to other measures (e.g., restriction of electrolyte intake, control of acidosis, high-calorie diet).b
Prior to initiating therapy, determine cause of hyperkalemia and eliminate if possible.b
Not recommended for treatment of hyperkalemia evidenced by conduction defects (widening of the QRS complex) or arrhythmiasb because action of the resin is slow.a b
Most useful when hyperkalemia is not life-threatening or when other measures have reduced the dangers of hyperkalemia.b
Dosage and duration of therapy must be individualized and depend on daily assessment of total body potassium.a b c
Administer orally or rectally.a b c
Administer orally as a suspension (either as the commercially available suspensionb c or prepared extemporaneously from the powdered resin).a b
Suspension also may be introduced into the stomach via a tube.a b c
Prior to administration, shake suspension well.c
Reconstitute each 1 g of the powdered resin in 3–4 mL of water or a syrup;a usually 20–100 mL of fluid is used.a b
Powdered resin may be mixed with a diet appropriate for a patient in renal failure.a c Do not mix with foods or liquids that contain a large amount of potassium (e.g., bananas, orange juice).b
Administer rectally as a retention enema by gravity feed (either as the commercially available suspensionb c or prepared extemporaneously from the powdered resin).a b
Prior to administration, administer an initial cleansing enema, and then insert a soft, large (French 28) rubber tube about 20 cm into the rectum, with the tip well into the sigmoid colon, and tape in place.a b c
Prior to administration, warm suspension to body temperaturea b and shake well.c
During administration, extemporaneously prepared suspension should be kept in suspension by stirring.a b The tube may be flushed with 50–100 mL of fluid, clamped, and left in place.a b c If back-leakage occurs, the hips should be elevated on pillows or a knee-chest position assumed.a b c
Retain suspension in the colon for at least 30–60 minutesb or for several hours if possible,a b c then irrigate the colon with a non-sodium containing solution at body temperature to remove the resin.a b Returns should be drained constantly through a Y tube connection.a c Approximately 2 L of irrigating solution may be needed to adequately flush out the resin;a b c proper removal of resin is particulary important when sorbitol is used.a
Alternatively, some clinicians recommend placing the resin in a sealed dialysis bag and inserting the bag into the rectum.b
Suspend appropriate dose of powdered resin in 100–200 mL of an aqueous vehicle (e.g., 25% sorbitol, 1% methylcellulose, 10% dextrose, water) at body temperature.b
A thicker suspension may be used; however, care should be taken that a paste, which would greatly reduce the exchange surface and be particularly ineffective if deposited in the rectal ampulla, is not formed.a b
Infants and small children: Reduced dosage recommended. Calculate dosage based on the fact that 1 g of the resin binds approximately 1 mEq of potassium.a b c
Oral administration not recommended in neonates.a (See Contraindications under Cautions.)
Reduced dosage recommended.a Calculate dosage based on the fact that 1 g of the resin binds approximately 1 mEq of potassium.a b c
Use with caution.a (See Pediatric Use under Cautions.)
15 g (approximately 4 level teaspoonfuls of the powder or 60 mL of the commercially available suspension) 1–4 times daily (average 15–60 g daily).a b c
30–50 g (120–200 mL of the commercially available suspension)a b c every 6 hours or as necessary.a b c
15 g 4 times daily (60 g daily).a b c
50 g every 6 hours.a b c
Hypokalemia.a
Obstructive bowel disease.a
Neonates with decreased gut mobility (postoperative or drug induced).a
Oral administration in neonates.a
Known hypersensitivity to sodium polystyrene sulfonate resins or any ingredient in the formulation.a c
Because of its slow action, sodium polystyrene sulfonate alone may be insufficient (effective lowering of serum potassium may occur within hours to days) to rapidly correct severe hyperkalemia, including that associated with states of rapid tissue breakdown (e.g., burns, renal failure).a b c If severe hyperkalemia occurs, consider other definitive measures, including dialysis.a b c
Possible severe hypokalemia (manifested by irritable confusion, delayed thought processes, muscle cramps, muscle weakness, and, occasionally, frank paralysis),a b c electrocardiogram (ECG) abnormalities (e.g., lengthened QT intervals; widened, flat, or inverted T waves; prominent U waves), and cardiac abnormalities (e.g., premature atrial, nodal, or ventricular contractions; supraventricular and ventricular tachycardias) may occur.a b c
Intracellular potassium deficiency is not always reflected by serum potassium levels; individualize decision to discontinue sodium polystyrene sulfonate therapy, taking into account patient's clinical condition and ECG.a c
Cation-exchange action is not totally selective for potassium; possible increased excretion of other cations (e.g., magnesium, calcium).a b c
Systemic alkalosis reported after oral administration of cation-exchange resins in combination with nonabsorbable cation-donating antacids and laxatives (e.g., magnesium hydroxide, aluminum carbonate). (See Specific Drugs under Interactions).a b c
Determine serum potassium concentrations at least daily during therapy.a
Monitor for other electrolyte (e.g., calcium, magnesium) abnormalities.b
Closely monitor ECGs and clinical condition of the patient during therapy.b
Each 1 g of the powdered resin contains approximately 4.1 mEq of sodium;a b each 60 mL of the commercially available suspension contains 65 mEq of sodium.c
Clinically important sodium retention may occur.a Use with caution in patients who cannot tolerate even a small increase in sodium loads (e.g., severe CHF, severe hypertension, marked edema); restriction of sodium intake from other sources may be required.a b c
Possible constipation.a If clinically important constipation occurs, discontinue therapy until normal bowel movements resume; administration of magnesium-containing laxatives and sorbitol not recommended.a (See Specific Drugs under Interactions.)
Category C.a c
Not known whether sodium polystyrene sulfonate is distributed into milk.a Caution if used in nursing women.a c
Efficacy not established.a
Oral administration not recommended in neonates.a Contraindicated in neonates with reduced gut motility (postoperatively or drug induced).a
Administer rectally with caution; excessive dosages or inadequate dilution may result in fecal impaction.a
Possible risk of digestive hemmorhage or colonic necrosis in premature infants or low birth weight infants; use with caution.a
Large doses in geriatric individuals may cause fecal impaction.a
Severe systemic alkalosis and a tonic-clonic seizure reported in one patient with chronic hypocalcemia secondary to renal failure who received magnesium hydroxide and sodium polystyrene sulfonate concomitantly.a b c (See Systemic Alkalosis under Cautions and Specific Drugs under Interactions.)
Intestinal necrosis reported rarely following rectal administration of sodium polystyrene sulfonate in sorbitol in azotemic patients.a b c
Gastric irritation.a b c Anorexia, nausea, vomiting, and constipation may occur with high doses.a c
Drug | Interaction | Comments |
|---|---|---|
Antacids, cation-donating (e.g., aluminum carbonate, aluminum hydroxide, magnesium hydroxide, calcium carbonate) | Possible reduced potassium exchange capabilitya b c Concomitant oral administration of sodium polysytrene sulfonate may result in systemic alkalosisa b Possible intestinal obstruction with large doses of aluminum hydroxidea b c | Concomitant use of orally administered sodium polystyrene sulfonate with magnesium hydroxide not recommendeda c Rectal use of sodium polystyrene sulfonate may avoid systemic alkalosisb c |
Cardiac glycosides | Sodium polystyrene sulfonate-induced hypokalemia may increase toxic effects of cardiac glycosides on the heart (e.g., ventricular arrhythmias, AV nodal dissociation)a (See Hypokalemia under Cautions) | |
Laxatives, cation-donating | Possible reduced potassium exchange capabilitya b Concomitant oral administration of sodium polysytrene sulfonate may result in systemic alkalosisa b | Concomitant use of orally administered sodium polystyrene sulfonate with magnesium hydroxide not recommendeda Rectal use of sodium polystyrene sulfonate may avoid systemic alkalosis)b |
Lithium | Possible decreased absorption of lithium a | |
Sorbitol | Possible intestinal necrosis a | Concomitant administration not recommendeda |
Thyroxine | Possible decreased absorption of thyroxine a |
Following administration, effective lowering of serum potassium may take hours to days.a c
Modified resin is excreted in the feces.b
25°C (may be exposed to 15–30°C).a
Tight container at 15–30°C.b c
Extemporaneous suspensions of the resin should be freshly prepared and should not be stored for >24 hours.a b
Suspension should not be heated because changes in the exchange properties of the resin may occur.a b c
A cation-exchange resin used for the removal of excess potassium.a b c
Releases sodium in exchange for other cations (e.g., potassium, calcium, magnesium, iron, organic cations, lipids, steroids, proteins).b
Sodium is released from the resin in exchange for potassium primarily in the large intestine, where there is a relatively high concentration of potassium present.a b Each 1 g of the resin has an in vitro exchange capacity of about 3.1 mEq of potassium; an in vivo exchange capacity >1 mEq of potassium per g of resin is not likely.b
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as any concomitant illnesses.a
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.a
Importance of informing patients of other important precautionary information.a (See Cautions.)
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Oral or Rectal | Powder, for suspension | Kayexalate | Sanofi-Aventis | |
Kionex | Paddock | |||
Sodium Polystyrene Sulfonate Powder | Carolina Medical | |||
Suspension | 1.25 g/5 mL* | Sodium Polystyrene Sulfonate Suspension (with alcohol, parabens, propylene glycol, and sorbitol solution) | Roxane | |
SPS (with alcohol, parabens, propylene glycol, and sorbitol solution) | Carolina Medical | |||
Rectal | Suspension | 1.25 g/5 mL* | Sodium Polystyrene Sulfonate Suspension Retention Enema (with alcohol, parabens, propylene glycol, and sorbitol solution) | Roxane |
SPS (with alcohol, parabens, propylene glycol, and sorbitol solution; with enema kit) | Carolina Medical |
This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 03/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.
Kayexalate Powder (SANOFI-AVENTIS U.S.): 453/$374 or 1360/$1095
Kionex Powder (PADDOCK): 454/$175.99 or 1362/$502.97
Sodium Polystyrene Sulfonate Powder (CAROLINA MEDICAL PRODUCTS): 454/$142.97 or 1362/$416.89
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions July 2006. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
100. Lillemoe KD, Romolo JL, Hamilton SR et al. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery. 1987; 101:267-72. [PubMed 3824154]
101. Wootton FT, Rhodes DF, Lee WM et al. Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation. Ann Intern Med. 1989; 111:947-9. [IDIS 261438] [PubMed 2817643]
102. Arvanitakis C, Malek G, Uehling D et al. Colonic complications after renal transplantation. Gastroenterology. 1973; 64:533-8. [PubMed 4144776]
103. Burnett RJ. Sodium polystyrene-sorbitol enemas. Ann Intern Med. 1990; 112:311-2. [IDIS 263378] [PubMed 2297214]
104. Shepard KV. Cleansing enemas after sodium polystyrene sulfonate enemas. Ann Intern Med. 1990; 112:711. [IDIS 265446] [PubMed 2334084]
a. Sanofi-Synthelabo. Kayexalate (sodium polystyrene sulfonate) prescribing information. New York, NY: 2003 Sep.
b. AHFS Drug Information 2005. McEvoy, GK, ed. Sodium Polystyrene Sulfonate. Bethesda, MD: American Society of Health-System Pharmacists; 2005: 2550-1.
c. Roxane Laboratories. Sodium polystyrene sulfonate suspension prescribing information. Columbus, OH: 1998 Sep.
Idealite may be available in the countries listed below.
Diacerein is reported as an ingredient of Idealite in the following countries:
International Drug Name Search
Definition of Hairy Cell Leukemia: A cancer of lymphocytes (B cells) that leads to low blood counts.
The following drugs and medications are in some way related to, or used in the treatment of Hairy Cell Leukemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Micromedex Care Notes:
Medical Encyclopedia:
Generic Name: multivitamin with iron (MUL tee VYE ta mins with i ron)
Brand Names:
Multivitamin are a combination of many different vitamins that are normally found in foods and other natural sources.
Iron is normally found in foods like red meat. In the body, iron becomes a part of your hemoglobin (HEEM o glo bin) and myoglobin (MY o glo bin). Hemoglobin carries oxygen through your blood to tissues and organs. Myoglobin helps your muscle cells store oxygen.
Multivitamin and iron are used to provide vitamins and iron that are not taken in through the diet. They are also used to treat iron or vitamin deficiencies caused by illness, pregnancy, poor nutrition, digestive disorders, and many other conditions.
Multivitamin and iron may also be used for other purposes not listed in this medication guide.
Overdose symptoms may include severe stomach pain, vomiting, bloody diarrhea, coughing up blood, constipation, loss of appetite, hair loss, peeling skin, warmth or tingly feeling, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine or stools, black and tarry stools, pale skin, easy bruising or bleeding, weakness, shallow breathing, weak and rapid pulse, pale skin, blue lips, and seizure (convulsions).
If you have any medical conditions, ask your doctor before taking a multivitamin with iron. If you have certain conditions, you may need a certain vitamin formulation or special tests while taking this product.
Use this medication as directed on the label, or as your doctor has prescribed. Do not use the medication in larger amounts or for longer than recommended.
Many multivitamin products also contain minerals such as calcium, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.
The chewable tablet must be chewed or allowed to dissolve in the mouth before swallowing.
Measure the liquid form of this multivitamin using a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.
Liquid multivitamin may sometimes be mixed with water, fruit juice, or infant formula (but not milk or other dairy products). Follow the directions on the medicine label.
It is important to take multivitamin with iron regularly to get the most benefit.
Store multivitamin in their original container. Storing multivitamin in a glass container can ruin the medication.
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include severe stomach pain, vomiting, bloody diarrhea, coughing up blood, constipation, loss of appetite, hair loss, peeling skin, warmth or tingly feeling, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine or stools, black and tarry stools, pale skin, easy bruising or bleeding, weakness, shallow breathing, weak and rapid pulse, pale skin, blue lips, and seizure (convulsions).
Avoid the regular use of salt substitutes in your diet if your multivitamin contains potassium. If you are on a low-salt diet, ask your doctor before taking a vitamin or mineral supplement.
Avoid taking an antibiotic medicine within 2 hours before or after you take multivitamin with iron. This is especially important if you are taking an antibiotic such as ciprofloxacin (Cipro), demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), levofloxacin (Levaquin), lomefloxacin (Maxaquin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), norfloxacin (Noroxin), ofloxacin (Floxin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).
Certain foods can also make it harder for your body to absorb iron. Avoid taking this multivitamin within 1 hour before or 2 hours after eating fish, meat, liver, and whole grain or "fortified" breads or cereals.
bright red blood in your stools; or
pain in your chest or throat when swallowing a ferrous fumarate tablet.
When taken as directed, multivitamin are not expected to cause serious side effects. Less serious side effects may include:
constipation, diarrhea;
nausea, vomiting, heartburn;
stomach pain, upset stomach;
black or dark-colored stools or urine;
temporary staining of the teeth;
headache; or
unusual or unpleasant taste in your mouth.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Vitamin and mineral supplements can interact with certain medications, or affect how medications work in your body. Before taking multivitamin with iron, tell your doctor if you also use:
acetohydroxamic acid (Lithostat);
cimetidine (Tagamet);
deferoxamine (Desferal);
etidronate (Didronel);
diuretics (water pills);
heart or blood pressure medications;
tretinoin (Vesanoid);
isotretinoin (Accutane, Amnesteen, Clavaris, Sotret);
dimercaprol (an injection used to treat poisoning by arsenic, lead, or mercury);
penicillamine (Cuprimine);
pancrelipase (Cotazym, Creon, Ilozyme, Pancrease, Ultrase);
trimethoprim and sulfamethoxazole (Cotrim, Bactrim, Septra, TMP/SMX); or
an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), ketoprofen (Orudis), and others.
This list is not complete and there may be other medications that can interact with or be affected by multivitamin with iron. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: Equicyte Plus side effects (in more detail)
The following drugs and medications are in some way related to, or used in the treatment of Follicle Stimulation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
